Ovarian cancer future or investigational therapies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
Overview
Overview
Epithelial ovarian cancer patients can have better prognosis and outcome with some under trial Medications that believed to be promising in the future. Examples of the mechanism of action of these promising drugs are, targeting the angiogenesis, targeting (inhibit) DNA repair, targeting cell cycle, targeting signaling pathways, immunotherapeutic medications.
Investigational therapies
Investigational therapies
- Epithelial ovarian cancer patients can have better prognosis and outcome with some under trial Medications that believed to be promising in the future
- Examples of the mechanism of action of these promising drugs are:
- Targeting the angiogenesis
- Targeting (inhibit) DNA repair
- Targeting cell cycle
- Targeting signaling pathways
- Immunotherapeutic medications
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
